These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3499541)

  • 21. Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group.
    Shimoyama M; Tobinai K; Yamaguchi K; Hirashima K; Itoh S; Konishi H; Mikuni C; Togawa A; Hotta T; Toyoda N
    Jpn J Clin Oncol; 1992 Dec; 22(6):406-10. PubMed ID: 1291757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to 2'-deoxycoformycin after failure of interferon-alpha in nonsplenectomized patients with hairy cell leukemia.
    Foon KA; Nakano GM; Koller CA; Longo DL; Steis RG
    Blood; 1986 Jul; 68(1):297-300. PubMed ID: 3487358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
    Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
    Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deoxycoformycin: a new chemotherapeutic agent of interest to dermatologists.
    Camisa C; Grever MR; Bouroncle B
    J Am Acad Dermatol; 1985 Jun; 12(6):1108-9. PubMed ID: 3874216
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hairy cell leukemia. A therapeutical update.
    Damasio EE; Pagnucco G; Federico M; Annino L; Chisesi T; Lamparelli T; Lauria F; Castoldi G; Resegotti L
    Haematologica; 1989; 74(2):205-18. PubMed ID: 2473014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of Waldenstrom's macroglobulinemia to pentostatin (2'-deoxycoformycin).
    Riddell S; Johnston JB; Rayner HL; Israels LG
    Cancer Treat Rep; 1986 Apr; 70(4):546-8. PubMed ID: 3084084
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
    Shibata T; Hotta T
    Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxycoformycin in therapy of refractory lymphoid neoplasms.
    Ho AD; Thaler J; Kuse R; Willemze R; Mandelli F; Lauria F; Zittoun R; Stryckmans P
    Onkologie; 1988 Feb; 11(1):35-7. PubMed ID: 3283623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
    Urba WJ; Baseler MW; Kopp WC; Steis RG; Clark JW; Smith JW; Coggin DL; Longo DL
    Blood; 1989 Jan; 73(1):38-46. PubMed ID: 2783373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful treatment with 2'-deoxycoformycin in a case of adult T-cell leukemia].
    Ishii M; Yamaguchi K; Yul LS; Oda T; Takatsuki K
    Rinsho Ketsueki; 1986 May; 27(5):780-3. PubMed ID: 3018324
    [No Abstract]   [Full Text] [Related]  

  • 32. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.
    Dillman RO; Mick R; McIntyre OR
    J Clin Oncol; 1989 Apr; 7(4):433-8. PubMed ID: 2784491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
    Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
    Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
    O'Dwyer PJ; Wagner B; Leyland-Jones B; Wittes RE; Cheson BD; Hoth DF
    Ann Intern Med; 1988 May; 108(5):733-43. PubMed ID: 3282467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.
    Poplack DG; Sallan SE; Rivera G; Holcenberg J; Murphy SB; Blatt J; Lipton JM; Venner P; Glaubiger DL; Ungerleider R; Johns D
    Cancer Res; 1981 Sep; 41(9 Pt 1):3343-6. PubMed ID: 6973390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies.
    Spiers AS
    Blood Rev; 1987 Jun; 1(2):106-10. PubMed ID: 3332090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose deoxycoformycin in the treatment of hairy cell leukemia.
    Kraut EH; Bouroncle BA; Grever MR
    Blood; 1986 Nov; 68(5):1119-22. PubMed ID: 3490287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin.
    Thaler J; Denz H; Dietze O; Gastl G; Ho AD; Gattringer C; Greil R; Lechleitner M; Huber C; Huber H
    Leuk Res; 1989; 13(5):377-83. PubMed ID: 2787447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentostatin induces durable remissions in hairy cell leukemia.
    Cassileth PA; Cheuvart B; Spiers AS; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    J Clin Oncol; 1991 Feb; 9(2):243-6. PubMed ID: 1988572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.